Anna Mowry - 27 Jun 2022 Form 4 Insider Report for Nautilus Biotechnology, Inc. (NAUT)

Role
CFO and Treasurer
Signature
/s/ Matthew B. Murphy, as Attorney-in-Fact
Issuer symbol
NAUT
Transactions as of
27 Jun 2022
Net transactions value
+$15,124
Form type
4
Filing time
28 Jun 2022, 18:17:38 UTC
Previous filing
25 Feb 2022
Next filing
22 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NAUT Common Stock Purchase $15,124 +5,500 +16% $2.75 39,250 27 Jun 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 1,250 shares of Common Stock acquired on June 1, 2022 through the Issuer's 2021 Employee Stock Purchase Plan.